Global Sarcopenia Therapeutic Market Research Report 2023
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
According to QYResearch’s new survey, global Sarcopenia Therapeutic market is projected to reach US$ 3670 million in 2029, increasing from US$ 2762.8 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sarcopenia Therapeutic market research.
The Sarcopenia Supplement market is primarily driven by the aging global population and the increasing awareness of age-related muscle loss. Sarcopenia supplements, designed to support muscle health and prevent muscle deterioration, cater to the growing demand for proactive approaches to healthy aging. The desire to maintain mobility, independence, and overall quality of life among the elderly population contributes to market growth. However, challenges include the need for well-researched and evidence-based formulations that effectively address muscle loss. Navigating regulatory requirements and ensuring consumer trust in supplement efficacy are ongoing concerns. Moreover, the market faces competition from various dietary and lifestyle interventions for muscle health. The market's success hinges on scientific advancements in supplement formulation, rigorous clinical testing, and educational efforts to inform both consumers and healthcare professionals about the benefits and appropriate use of sarcopenia supplements.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sarcopenia Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Sarcopenia Therapeutic market is projected to reach US$ 3670 million in 2029, increasing from US$ 2762.8 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sarcopenia Therapeutic market research.
The Sarcopenia Supplement market is primarily driven by the aging global population and the increasing awareness of age-related muscle loss. Sarcopenia supplements, designed to support muscle health and prevent muscle deterioration, cater to the growing demand for proactive approaches to healthy aging. The desire to maintain mobility, independence, and overall quality of life among the elderly population contributes to market growth. However, challenges include the need for well-researched and evidence-based formulations that effectively address muscle loss. Navigating regulatory requirements and ensuring consumer trust in supplement efficacy are ongoing concerns. Moreover, the market faces competition from various dietary and lifestyle interventions for muscle health. The market's success hinges on scientific advancements in supplement formulation, rigorous clinical testing, and educational efforts to inform both consumers and healthcare professionals about the benefits and appropriate use of sarcopenia supplements.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sarcopenia Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Abbott Laboratories
- Nestlй
- Pfizer
- Amway
- By-health
- Usana
- A&Z Pharmaceutical
- GlaxoSmithKline
- Bayer
- H&H
- Blackmores
- Zhendong Group
- Protein Supplement
- Calcium Supplement
- Other
- Online Pharmacies
- Retail Pharmacies
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sarcopenia Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Protein Supplement
1.2.3 Calcium Supplement
1.2.4 Other
1.3 Market by Application
1.3.1 Global Sarcopenia Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Sarcopenia Therapeutic Market Perspective (2018-2029)
2.2 Sarcopenia Therapeutic Growth Trends by Region
2.2.1 Global Sarcopenia Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sarcopenia Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Sarcopenia Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Sarcopenia Therapeutic Market Dynamics
2.3.1 Sarcopenia Therapeutic Industry Trends
2.3.2 Sarcopenia Therapeutic Market Drivers
2.3.3 Sarcopenia Therapeutic Market Challenges
2.3.4 Sarcopenia Therapeutic Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Sarcopenia Therapeutic Players by Revenue
3.1.1 Global Top Sarcopenia Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Sarcopenia Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Sarcopenia Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sarcopenia Therapeutic Revenue
3.4 Global Sarcopenia Therapeutic Market Concentration Ratio
3.4.1 Global Sarcopenia Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sarcopenia Therapeutic Revenue in 2022
3.5 Sarcopenia Therapeutic Key Players Head office and Area Served
3.6 Key Players Sarcopenia Therapeutic Product Solution and Service
3.7 Date of Enter into Sarcopenia Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SARCOPENIA THERAPEUTIC BREAKDOWN DATA BY TYPE
4.1 Global Sarcopenia Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Sarcopenia Therapeutic Forecasted Market Size by Type (2024-2029)
5 SARCOPENIA THERAPEUTIC BREAKDOWN DATA BY APPLICATION
5.1 Global Sarcopenia Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Sarcopenia Therapeutic Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Sarcopenia Therapeutic Market Size (2018-2029)
6.2 North America Sarcopenia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sarcopenia Therapeutic Market Size by Country (2018-2023)
6.4 North America Sarcopenia Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Sarcopenia Therapeutic Market Size (2018-2029)
7.2 Europe Sarcopenia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sarcopenia Therapeutic Market Size by Country (2018-2023)
7.4 Europe Sarcopenia Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Sarcopenia Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Sarcopenia Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Sarcopenia Therapeutic Market Size (2018-2029)
9.2 Latin America Sarcopenia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sarcopenia Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Sarcopenia Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Sarcopenia Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Sarcopenia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Sarcopenia Therapeutic Introduction
11.1.4 Abbott Laboratories Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Nestlй
11.2.1 Nestlй Company Detail
11.2.2 Nestlй Business Overview
11.2.3 Nestlй Sarcopenia Therapeutic Introduction
11.2.4 Nestlй Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.2.5 Nestlй Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Sarcopenia Therapeutic Introduction
11.3.4 Pfizer Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Amway
11.4.1 Amway Company Detail
11.4.2 Amway Business Overview
11.4.3 Amway Sarcopenia Therapeutic Introduction
11.4.4 Amway Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.4.5 Amway Recent Development
11.5 By-health
11.5.1 By-health Company Detail
11.5.2 By-health Business Overview
11.5.3 By-health Sarcopenia Therapeutic Introduction
11.5.4 By-health Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.5.5 By-health Recent Development
11.6 Usana
11.6.1 Usana Company Detail
11.6.2 Usana Business Overview
11.6.3 Usana Sarcopenia Therapeutic Introduction
11.6.4 Usana Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.6.5 Usana Recent Development
11.7 A&Z Pharmaceutical
11.7.1 A&Z Pharmaceutical Company Detail
11.7.2 A&Z Pharmaceutical Business Overview
11.7.3 A&Z Pharmaceutical Sarcopenia Therapeutic Introduction
11.7.4 A&Z Pharmaceutical Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.7.5 A&Z Pharmaceutical Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sarcopenia Therapeutic Introduction
11.8.4 GlaxoSmithKline Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Sarcopenia Therapeutic Introduction
11.9.4 Bayer Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 H&H
11.10.1 H&H Company Detail
11.10.2 H&H Business Overview
11.10.3 H&H Sarcopenia Therapeutic Introduction
11.10.4 H&H Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.10.5 H&H Recent Development
11.11 Blackmores
11.11.1 Blackmores Company Detail
11.11.2 Blackmores Business Overview
11.11.3 Blackmores Sarcopenia Therapeutic Introduction
11.11.4 Blackmores Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.11.5 Blackmores Recent Development
11.12 Zhendong Group
11.12.1 Zhendong Group Company Detail
11.12.2 Zhendong Group Business Overview
11.12.3 Zhendong Group Sarcopenia Therapeutic Introduction
11.12.4 Zhendong Group Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.12.5 Zhendong Group Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sarcopenia Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Protein Supplement
1.2.3 Calcium Supplement
1.2.4 Other
1.3 Market by Application
1.3.1 Global Sarcopenia Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Sarcopenia Therapeutic Market Perspective (2018-2029)
2.2 Sarcopenia Therapeutic Growth Trends by Region
2.2.1 Global Sarcopenia Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sarcopenia Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Sarcopenia Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Sarcopenia Therapeutic Market Dynamics
2.3.1 Sarcopenia Therapeutic Industry Trends
2.3.2 Sarcopenia Therapeutic Market Drivers
2.3.3 Sarcopenia Therapeutic Market Challenges
2.3.4 Sarcopenia Therapeutic Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Sarcopenia Therapeutic Players by Revenue
3.1.1 Global Top Sarcopenia Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Sarcopenia Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Sarcopenia Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sarcopenia Therapeutic Revenue
3.4 Global Sarcopenia Therapeutic Market Concentration Ratio
3.4.1 Global Sarcopenia Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sarcopenia Therapeutic Revenue in 2022
3.5 Sarcopenia Therapeutic Key Players Head office and Area Served
3.6 Key Players Sarcopenia Therapeutic Product Solution and Service
3.7 Date of Enter into Sarcopenia Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SARCOPENIA THERAPEUTIC BREAKDOWN DATA BY TYPE
4.1 Global Sarcopenia Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Sarcopenia Therapeutic Forecasted Market Size by Type (2024-2029)
5 SARCOPENIA THERAPEUTIC BREAKDOWN DATA BY APPLICATION
5.1 Global Sarcopenia Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Sarcopenia Therapeutic Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Sarcopenia Therapeutic Market Size (2018-2029)
6.2 North America Sarcopenia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sarcopenia Therapeutic Market Size by Country (2018-2023)
6.4 North America Sarcopenia Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Sarcopenia Therapeutic Market Size (2018-2029)
7.2 Europe Sarcopenia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sarcopenia Therapeutic Market Size by Country (2018-2023)
7.4 Europe Sarcopenia Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Sarcopenia Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Sarcopenia Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Sarcopenia Therapeutic Market Size (2018-2029)
9.2 Latin America Sarcopenia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sarcopenia Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Sarcopenia Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Sarcopenia Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Sarcopenia Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Sarcopenia Therapeutic Introduction
11.1.4 Abbott Laboratories Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Nestlй
11.2.1 Nestlй Company Detail
11.2.2 Nestlй Business Overview
11.2.3 Nestlй Sarcopenia Therapeutic Introduction
11.2.4 Nestlй Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.2.5 Nestlй Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Sarcopenia Therapeutic Introduction
11.3.4 Pfizer Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Amway
11.4.1 Amway Company Detail
11.4.2 Amway Business Overview
11.4.3 Amway Sarcopenia Therapeutic Introduction
11.4.4 Amway Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.4.5 Amway Recent Development
11.5 By-health
11.5.1 By-health Company Detail
11.5.2 By-health Business Overview
11.5.3 By-health Sarcopenia Therapeutic Introduction
11.5.4 By-health Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.5.5 By-health Recent Development
11.6 Usana
11.6.1 Usana Company Detail
11.6.2 Usana Business Overview
11.6.3 Usana Sarcopenia Therapeutic Introduction
11.6.4 Usana Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.6.5 Usana Recent Development
11.7 A&Z Pharmaceutical
11.7.1 A&Z Pharmaceutical Company Detail
11.7.2 A&Z Pharmaceutical Business Overview
11.7.3 A&Z Pharmaceutical Sarcopenia Therapeutic Introduction
11.7.4 A&Z Pharmaceutical Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.7.5 A&Z Pharmaceutical Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Sarcopenia Therapeutic Introduction
11.8.4 GlaxoSmithKline Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Sarcopenia Therapeutic Introduction
11.9.4 Bayer Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 H&H
11.10.1 H&H Company Detail
11.10.2 H&H Business Overview
11.10.3 H&H Sarcopenia Therapeutic Introduction
11.10.4 H&H Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.10.5 H&H Recent Development
11.11 Blackmores
11.11.1 Blackmores Company Detail
11.11.2 Blackmores Business Overview
11.11.3 Blackmores Sarcopenia Therapeutic Introduction
11.11.4 Blackmores Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.11.5 Blackmores Recent Development
11.12 Zhendong Group
11.12.1 Zhendong Group Company Detail
11.12.2 Zhendong Group Business Overview
11.12.3 Zhendong Group Sarcopenia Therapeutic Introduction
11.12.4 Zhendong Group Revenue in Sarcopenia Therapeutic Business (2018-2023)
11.12.5 Zhendong Group Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Sarcopenia Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Protein Supplement
Table 3. Key Players of Calcium Supplement
Table 4. Key Players of Other
Table 5. Global Sarcopenia Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Sarcopenia Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Sarcopenia Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sarcopenia Therapeutic Market Share by Region (2018-2023)
Table 9. Global Sarcopenia Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Sarcopenia Therapeutic Market Share by Region (2024-2029)
Table 11. Sarcopenia Therapeutic Market Trends
Table 12. Sarcopenia Therapeutic Market Drivers
Table 13. Sarcopenia Therapeutic Market Challenges
Table 14. Sarcopenia Therapeutic Market Restraints
Table 15. Global Sarcopenia Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sarcopenia Therapeutic Market Share by Players (2018-2023)
Table 17. Global Top Sarcopenia Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Therapeutic as of 2022)
Table 18. Ranking of Global Top Sarcopenia Therapeutic Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sarcopenia Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sarcopenia Therapeutic Product Solution and Service
Table 22. Date of Enter into Sarcopenia Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sarcopenia Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sarcopenia Therapeutic Revenue Market Share by Type (2018-2023)
Table 26. Global Sarcopenia Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Sarcopenia Therapeutic Revenue Market Share by Type (2024-2029)
Table 28. Global Sarcopenia Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sarcopenia Therapeutic Revenue Market Share by Application (2018-2023)
Table 30. Global Sarcopenia Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Sarcopenia Therapeutic Revenue Market Share by Application (2024-2029)
Table 32. North America Sarcopenia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Sarcopenia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sarcopenia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Sarcopenia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Sarcopenia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Sarcopenia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Sarcopenia Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Sarcopenia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Sarcopenia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Sarcopenia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Sarcopenia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Sarcopenia Therapeutic Product
Table 50. Abbott Laboratories Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Nestlй Company Detail
Table 53. Nestlй Business Overview
Table 54. Nestlй Sarcopenia Therapeutic Product
Table 55. Nestlй Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 56. Nestlй Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Sarcopenia Therapeutic Product
Table 60. Pfizer Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Amway Company Detail
Table 63. Amway Business Overview
Table 64. Amway Sarcopenia Therapeutic Product
Table 65. Amway Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 66. Amway Recent Development
Table 67. By-health Company Detail
Table 68. By-health Business Overview
Table 69. By-health Sarcopenia Therapeutic Product
Table 70. By-health Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 71. By-health Recent Development
Table 72. Usana Company Detail
Table 73. Usana Business Overview
Table 74. Usana Sarcopenia Therapeutic Product
Table 75. Usana Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 76. Usana Recent Development
Table 77. A&Z Pharmaceutical Company Detail
Table 78. A&Z Pharmaceutical Business Overview
Table 79. A&Z Pharmaceutical Sarcopenia Therapeutic Product
Table 80. A&Z Pharmaceutical Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 81. A&Z Pharmaceutical Recent Development
Table 82. GlaxoSmithKline Company Detail
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Sarcopenia Therapeutic Product
Table 85. GlaxoSmithKline Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Sarcopenia Therapeutic Product
Table 90. Bayer Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. H&H Company Detail
Table 93. H&H Business Overview
Table 94. H&H Sarcopenia Therapeutic Product
Table 95. H&H Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 96. H&H Recent Development
Table 97. Blackmores Company Detail
Table 98. Blackmores Business Overview
Table 99. Blackmores Sarcopenia Therapeutic Product
Table 100. Blackmores Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 101. Blackmores Recent Development
Table 102. Zhendong Group Company Detail
Table 103. Zhendong Group Business Overview
Table 104. Zhendong Group Sarcopenia Therapeutic Product
Table 105. Zhendong Group Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 106. Zhendong Group Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 1. Global Sarcopenia Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Protein Supplement
Table 3. Key Players of Calcium Supplement
Table 4. Key Players of Other
Table 5. Global Sarcopenia Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Sarcopenia Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Sarcopenia Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sarcopenia Therapeutic Market Share by Region (2018-2023)
Table 9. Global Sarcopenia Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Sarcopenia Therapeutic Market Share by Region (2024-2029)
Table 11. Sarcopenia Therapeutic Market Trends
Table 12. Sarcopenia Therapeutic Market Drivers
Table 13. Sarcopenia Therapeutic Market Challenges
Table 14. Sarcopenia Therapeutic Market Restraints
Table 15. Global Sarcopenia Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sarcopenia Therapeutic Market Share by Players (2018-2023)
Table 17. Global Top Sarcopenia Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Therapeutic as of 2022)
Table 18. Ranking of Global Top Sarcopenia Therapeutic Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sarcopenia Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sarcopenia Therapeutic Product Solution and Service
Table 22. Date of Enter into Sarcopenia Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sarcopenia Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sarcopenia Therapeutic Revenue Market Share by Type (2018-2023)
Table 26. Global Sarcopenia Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Sarcopenia Therapeutic Revenue Market Share by Type (2024-2029)
Table 28. Global Sarcopenia Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sarcopenia Therapeutic Revenue Market Share by Application (2018-2023)
Table 30. Global Sarcopenia Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Sarcopenia Therapeutic Revenue Market Share by Application (2024-2029)
Table 32. North America Sarcopenia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Sarcopenia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sarcopenia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Sarcopenia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Sarcopenia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Sarcopenia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Sarcopenia Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Sarcopenia Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Sarcopenia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Sarcopenia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Sarcopenia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Sarcopenia Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Sarcopenia Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Sarcopenia Therapeutic Product
Table 50. Abbott Laboratories Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Nestlй Company Detail
Table 53. Nestlй Business Overview
Table 54. Nestlй Sarcopenia Therapeutic Product
Table 55. Nestlй Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 56. Nestlй Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Sarcopenia Therapeutic Product
Table 60. Pfizer Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Amway Company Detail
Table 63. Amway Business Overview
Table 64. Amway Sarcopenia Therapeutic Product
Table 65. Amway Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 66. Amway Recent Development
Table 67. By-health Company Detail
Table 68. By-health Business Overview
Table 69. By-health Sarcopenia Therapeutic Product
Table 70. By-health Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 71. By-health Recent Development
Table 72. Usana Company Detail
Table 73. Usana Business Overview
Table 74. Usana Sarcopenia Therapeutic Product
Table 75. Usana Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 76. Usana Recent Development
Table 77. A&Z Pharmaceutical Company Detail
Table 78. A&Z Pharmaceutical Business Overview
Table 79. A&Z Pharmaceutical Sarcopenia Therapeutic Product
Table 80. A&Z Pharmaceutical Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 81. A&Z Pharmaceutical Recent Development
Table 82. GlaxoSmithKline Company Detail
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Sarcopenia Therapeutic Product
Table 85. GlaxoSmithKline Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Sarcopenia Therapeutic Product
Table 90. Bayer Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. H&H Company Detail
Table 93. H&H Business Overview
Table 94. H&H Sarcopenia Therapeutic Product
Table 95. H&H Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 96. H&H Recent Development
Table 97. Blackmores Company Detail
Table 98. Blackmores Business Overview
Table 99. Blackmores Sarcopenia Therapeutic Product
Table 100. Blackmores Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 101. Blackmores Recent Development
Table 102. Zhendong Group Company Detail
Table 103. Zhendong Group Business Overview
Table 104. Zhendong Group Sarcopenia Therapeutic Product
Table 105. Zhendong Group Revenue in Sarcopenia Therapeutic Business (2018-2023) & (US$ Million)
Table 106. Zhendong Group Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Sarcopenia Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Sarcopenia Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Protein Supplement Features
Figure 4. Calcium Supplement Features
Figure 5. Other Features
Figure 6. Global Sarcopenia Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Sarcopenia Therapeutic Market Share by Application: 2022 VS 2029
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Sarcopenia Therapeutic Report Years Considered
Figure 11. Global Sarcopenia Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Sarcopenia Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sarcopenia Therapeutic Market Share by Region: 2022 VS 2029
Figure 14. Global Sarcopenia Therapeutic Market Share by Players in 2022
Figure 15. Global Top Sarcopenia Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Therapeutic as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Sarcopenia Therapeutic Revenue in 2022
Figure 17. North America Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Sarcopenia Therapeutic Market Share by Country (2018-2029)
Figure 19. United States Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Sarcopenia Therapeutic Market Share by Country (2018-2029)
Figure 23. Germany Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Sarcopenia Therapeutic Market Share by Region (2018-2029)
Figure 31. China Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Sarcopenia Therapeutic Market Share by Country (2018-2029)
Figure 39. Mexico Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Sarcopenia Therapeutic Market Share by Country (2018-2029)
Figure 43. Turkey Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 46. Nestlй Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 48. Amway Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 49. By-health Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 50. Usana Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 51. A&Z Pharmaceutical Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 54. H&H Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 55. Blackmores Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 56. Zhendong Group Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Figure 1. Global Sarcopenia Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Sarcopenia Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Protein Supplement Features
Figure 4. Calcium Supplement Features
Figure 5. Other Features
Figure 6. Global Sarcopenia Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Sarcopenia Therapeutic Market Share by Application: 2022 VS 2029
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Sarcopenia Therapeutic Report Years Considered
Figure 11. Global Sarcopenia Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Sarcopenia Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sarcopenia Therapeutic Market Share by Region: 2022 VS 2029
Figure 14. Global Sarcopenia Therapeutic Market Share by Players in 2022
Figure 15. Global Top Sarcopenia Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Therapeutic as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Sarcopenia Therapeutic Revenue in 2022
Figure 17. North America Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Sarcopenia Therapeutic Market Share by Country (2018-2029)
Figure 19. United States Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Sarcopenia Therapeutic Market Share by Country (2018-2029)
Figure 23. Germany Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Sarcopenia Therapeutic Market Share by Region (2018-2029)
Figure 31. China Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Sarcopenia Therapeutic Market Share by Country (2018-2029)
Figure 39. Mexico Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Sarcopenia Therapeutic Market Share by Country (2018-2029)
Figure 43. Turkey Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Sarcopenia Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 46. Nestlй Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 48. Amway Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 49. By-health Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 50. Usana Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 51. A&Z Pharmaceutical Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 54. H&H Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 55. Blackmores Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 56. Zhendong Group Revenue Growth Rate in Sarcopenia Therapeutic Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
